| Patents > Guidance, Tools, and Manuals > Classification > Class Schedule |
|
|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
|
| You are viewing a USPC Schedule. |
|
| Class 930 | PEPTIDE OR PROTEIN SEQUENCE |
| Click here for a printable version of this file | |
| CROSS-REFERENCE ART COLLECTIONS | ||
![[List of Pre Grant Publications for class 930 subclass 10]](../as.gif) | ![[List of Patents for class 930 subclass 10]](../ps.gif) | 10 | PEPTIDE OR PROTEIN SEQUENCE |
| | 20 |  Containing modified or unusual amino acid (See note 1 and note 2) |
| | 21 |  Containing D-amino acid |
| | 22 | Containing radioactive atom (See note 3) |
| | 23 | Containing halogen (See note 3) |
| | 24 | Containing sulfur (See note 4) |
| | 25 | Containing heavy metal or salt thereof |
| | 30 | Linear peptide or protein containing a nonpeptide or abnormal peptide link (See note 5) |
| | 40 | Angiotensin; related peptides |
| | 50 | Atrial or brain natriuretic peptide; related peptides |
| | 60 | Calcitonin; related peptides |
| | 70 | Corticotropin; related peptides |
| | 80 | Endorphin or Enkephalin; related peptides |
| | 90 | Erythropoietin; related peptides |
| | 100 | Factor VIII, AHF; related peptides |
| | 110 | Gonadotropin; related peptides |
| | 120 | Growth hormone, growth factor other than T-cell or B-cell growth factor, and growth hormone releasing factor; related peptides |
| | 130 | Luteinizing hormone-releasing hormone (LH-RH); related peptides |
| | 140 | Lymphokine; related peptides |
| | 141 | Interleukin |
| | 142 | Interferon |
| | 143 | Lymphotoxin |
| | 144 | Tumor necrosis factor |
| | 145 | Colony stimulating factor |
| | 150 | Oxytocin or vasopressin; related peptides |
| | 160 | Somatostatin; related peptides |
| | 170 | Vasoactive intestinal peptides; related peptides |
| | 180 | Thymus derived hormone or factor; related peptides |
| | 190 | Antibiotic |
| | 200 | Bacterial peptide or bacterial protein (See note 6) |
| | 210 | Parasitic peptide or parasitic protein (See note 6) |
| | 220 | Viral peptide or viral protein (See note 6) |
| | 221 | Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related |
| | 222 | Foot and mouth disease related |
| | 223 | Hepatitis related |
| | 224 | Herpes related |
| | 230 | Multicellular plant peptide or multicellular plant protein |
| | 240 | Enzyme or isoenzyme |
| | 250 | Enzyme inhibitor |
| | 260 | Containing Cys-Cys disulfide bridge between nonadjacent cysteine residues (See note 7) |
| | 270 | Cyclic peptide or cyclic protein (See note 8) |
| | 280 | Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin |
| | 290 | Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units |
| | 300 | Signal or leader sequence |
| | 310 | Linker sequence |
| | 320 | Modification to prevent enzymatic degradation (See note 9) |
| FOREIGN ART COLLECTIONS | ||
| FOR000 | CLASS-RELATED FOREIGN DOCUMENTS |
| DIGESTS | ||
| | DIG500 | PEPTIDES CONTAINING SACCHARIDE RADICALS AND HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS AND WHEREIN THE PEPTIDE SEQUENCE IS NOT PART OF A RING STRUCTURE, E.G., BLEOMYCIN, PHLEOMYCIN, MURAMYLPEPTIDES, ETC., (C07K-9/00D, 9/00D2, 9/00D4, 9/00D9) |
| | DIG510 | PEPTIDES CONTAINING SACCHRIDE RADICALS AND HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS WHEREIN THE PEPTIDE SEQUENCE IS PART OF A RING STRUCTURE AND IS DIRECTLY ATTACHED TO A HETERO ATOM OF THE SACCHARIDE ATOM, E.G., ACTAPLANIN, AVOPARCIN, RISTOMYCIN, VANCOMYCIN, ETC., (C07K 9/00F2) |
| | DIG520 | PEPTIDES CONTAINING SACCHARIDE RADICALS AND HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS WHEREIN THE PEPTIDE SEQUENCE IS PART OF A RING STRUCTURE AND IS NOT DIRECTLY ATTACHED TO A HETERO ATOM OF THE SACCHARIDE ATOM (C07K-9/00F4) |
| | DIG530 | PROTEINS HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS OR DERIVATIVES THEREOF, I.E., MORE THAN 100 AMINO ACIDS (C07K-13/00) |
| | DIG532 | CYCLIC PEPTIDES DERIVED FROM AT LEAST FIVE AMINO ACIDS AND CONTAINING AT LEAST ONE ABNORMAL PEPTIDE LINK (C07K-7/50) |
| | DIG533 | With only normal peptide links in the ring (C07K-7/52) |
| | DIG534 | With all amino acids in L-form (C07K-7/52A) |
| | DIG535 | With at least one amino acid in D-form (C07K-7/52B) |
| | DIG536 | With at least one abnormal peptide link in the ring (C07K-7/54) |
| | DIG546 | CYCLIC PEPTIDES DERIVED FROM AT LEAST FIVE AMINO ACIDS AND CONTAINING ONLY NORMAL PEPTIDE LINKS (C07K-7/64) |
| | DIG550 | PEPTIDES CONTAINING THE SEQUENCE (A-LEU-GLU-ILE-LYS-ORN-ILE-PHE-HIS-ASP-ASP NH2), A BEING H OR ILE-CYS, E.G., BACITRACINS A OR F OR RELATED PEPTIDES (C07K-99/00B) |
| | DIG551 | With all amino acids in L-form (C07K-99/00B1) |
| | DIG552 | With at least one amino acid in D-form (C07K-99/00B2) |
| | DIG553 | PEPTIDES CONTAINING THE C-TERMINAL SEQUENCE (X-CYS-PHE-GLY-PHE-GLY-GLY ARG-A-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-Y) WITH X BEING NH, Y BEING -OH, NH, OR PART OF THE SEQUENCE -ASN-SER-PHE-ARG-TYR-ARG-ARG- AND A BEING MET OR ILE, E.G., ATRIOPEPTINE; ATRIAL NATRIURETIC PEPTIDES AND PROTEINS (ANP) (C07K-99/00C) |
| | DIG554 | With all amino acids in L-form (C07K-99/00C1) |
| | DIG555 | With at least one amino acid in D-form (C07K-99/00C2) |
| | DIG556 | PEPTIDES CONTAINING THE SEQUENCE (ASP-PRO-A-TYR-B-C-VAL-SER-ASN-ALA-ASP-LEU MET-ASP- PHE-LYS-ASN-LEU-LEU-Y), WITH A, B, C BEING AMINO ACIDS, AND Y BEING A PEPTIDE SEQUENCE, E.G., CARDIODILATIN (SEE SUBCLASS 553 FOR PATENTS THAT CONTAIN THE AERIAL NATRIURETIC PEPTIDE SEQUENCE) (C07K-99/00D) |
| | DIG557 | With all amino acids in L-form (C07K-99/00D1) |
| | DIG558 | With at least one amino acid in D-form (C07K-99/00D2) |
| | DIG559 | PEPTIDES CONTAINING THE SEQUENCE (TYR-ALA-ASP-ALA-ILE-PHE-TYR -ASN-SER TYR-ARG-LYS-VAL -LEU-GLY-GLN-LEU-SER- ALA-ARG-LYS-LEU-LEU- GLN-ASP ILE-MET-A-ARG- GLN-GLN-GLY-GLU-B-ASN- GLN-GLU-C-GLY- -ALA-D-E ARG-LEU-NH) WITH A BEING SER OR ASN, B BEING SER OR ARG, C BEING ARG OR GLN, D BEING ARG OR LYS, AND E BEING ALA, VAL, OR PHE, E.G., SOMATOLIBERIN (GONADOTROPIN RELEASING FACTOR) (C07K-99/00F) |
| | DIG560 | PEPTIDES CONTAINING THE SEQUENCE (TYR-D-ALA-PHE-GLY-TYR -PRO-SER), E.G., DERMORPHIN (C07K-99/00H) |
| | DIG565 | PEPTIDES CONTAINING THE SEQUENCE (CYS-TYR-A-GLN-ASN-CYS-PRO-B -GLY NH2), WITH A BEING ILE OR PHE, B BEING LEU OR ARG OR LYS OR S-S BRIDGE 1-6, E.G., OXYTOCIN, VASOPRESSIN, OR A RELATED PEPTIDE (C07K 99/02) |
| | DIG566 | With all amino acids in L-form (C07K-99/02A) |
| | DIG567 | With at least one amino acid in D-form (C07K-99/04) |
| | DIG570 | PEPTIDES CONTAINING THE SEQUENCE (SER-TYR-SER-MET-GLU-HIS-PHE -ARG TRP-GLY-LYS-PRO-VAL-GLY -LYS-LYS-ARG-ARG-PRO-VAL-LYS -VAL-TYR-PRO ASP-GLY- A-B-C-D-E-ALA-GLU- ALA-PHE-PRO-LEU-GLU-PHE-OH), A-B-C-D-E BEING GLU-ALA-GLU-ASP-SER- OR ALA-GLU-ASP-GLU-LEU OR ALA-GLU-ASP-GLU-SER, E.G., CORTICOTROPIN (ACTH) OR RELATED PEPTIDES (C07K-99/06) |
| | DIG571 | With all amino acids in L-form (C07K-99/06A) |
| | DIG572 | With at least one amino acid in D-form (C07K-99/08) |
| | DIG580 | PEPTIDES CONTAINING THE SEQUENCE (CH3CO-SER-TYR-SER-MET-GLU -HIS-PHE ARG-TRP-GLY-LYS- PRO-VAL-NH2), E.G., A-MSH, OR RELATED PEPTIDES (FRAGMENTS WHICH ARE COMMON WITH DIGEST 570 ARE ALSO IN THAT CLASSIFICATION) (C07K-99/10) |
| | DIG581 | With all amino acids in L-form (C07K-99/10A) |
| | DIG582 | With at least one amino acid in D-form (C07K-99/12) |
| | DIG590 | PEPTIDES CONTAINING THE SEQUENCE (A-ARG-VAL-TYR-VAL- ILE- HIS-PRO-PHE-B), A BEING ASP OR ASN, AND B BEING -OH OR HIS-LEU-OH, E.G., ANGIOTENSIN I, PEPSITENSIN, OR RELATED PEPTIDES (C07K-99/14) |
| | DIG591 | With all amino acids in L-form (C07K-99/14A) |
| | DIG592 | With at least one amino acid in D-form (C07K-99/16) |
| | DIG600 | PEPTIDES CONTAINING THE SEQUENCE (A-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG OH), A BEING H OR LYS, E.G., KALLIDIN, BRADYKININ, ETC. OR RELATED PEPTIDES (C07K-99/18) |
| | DIG601 | With all amino acids in L-form (C07K-99/18A) |
| | DIG602 | With at least one amino acid in D-form (C07K-99/20) |
| | DIG610 | PEPTIDES CONTAINING THE SEQUENCE (PGL-PRO-SER-LYS-ASP-ALA-PHE -ILE GLY-LEU-MET-NH2), E.G., ELEDOISIN, OR RELATED PEPTIDES (C07K-99/22) |
| | DIG611 | With all amino acids in L-form (C07K-99/22A) |
| | DIG612 | With at least one amino acid in D-form (C07K-99/24) |
| | DIG620 | PEPTIDES CONTAINING THE SEQUENCE (GLY-ILE-VAL-GLU-GLN-CYS-CYS -A-B-C CYS-SER-LEU-TYR-GLN -LEU-GLU-ASN-TYR-CYS -ASN-PH) AND (PHE-VAL-ASN- GLN-HIS-LEU-CYS-GLY-SER- HIS-LEU-VAL-GLU-ALA-LEU- TYR-LEU-VAL-CYS GLY-GLU- ARG-GLY-PHE -PHE-TYR-TYR-PRO-LYS-D), A-B-C BEING -ALA-SER VAL-, OR -ALA-GLY-VAL-, OR -THR-SER-ILE-, OR -ALA-SER-VAL-, D BEING ALA-OH OR THR-OH, E.G., HUMAN INSULIN OR RELATED PEPTIDES (C07K-99/26) |
| | DIG621 | With all amino acids in L-form (C07K-99/26A) |
| | DIG622 | With at least one amino acid in D-form (C07K-99/28) |
| | DIG630 | PEPTIDES CONTAINING THE SEQUENCE (PGL-GLY-PRO-TRP-A-GLU-GLU- B-GLU-B ALA-TYR- GLY-TRP-MET- LEU- ASP-PHE- TYR- NH2, A BEING MET, LEU OR VAL, B BEING GLU OR ALA, E.G., GASTRIN OR RELATED PEPTIDES, ETC. (C07K 99/30) |
| | DIG631 | With all amino acids in L-form (C07K-99/30A) |
| | DIG632 | With at least one amino acid in D-form (C07K-99/32) |
| | DIG640 | PEPTIDES CONTAINING THE SEQUENCE (HIS-SER-GLN-GLY-THR-PHE-THR -SER ASP-TYR-LYS-SER- TYR-LEU-ASP-SER-ARG-ARG-ALA -GLN-ASP-PHE-VAL-GLN-TRP LEU- MET-ASN-THR-OH), E.G., GLUCAGON OR RELATED PEPTIDES, ETC. (C07K-99/34) |
| | DIG641 | With all amino acids in L-form (C07K-99/34A) |
| | DIG642 | With at least one amino acid in D-form (C07K-99/36) |
| | DIG650 | PEPTIDES CONTAINING THE SEQUENCE (HIS-SER-ASP-GLY-THR-PHE-THR -SER GLU-LEU-SER-ARG-LEU-ARG -ASP-SER-ALA-ARG-LEU-GLN-ARG -LEU-LEU-GLN GLY-LEU-VAL-NH2), E.G., SECRETIN OR RELATED PEPTIDES, ETC. (FRAGMENTS CONTAINING THE UNCHANGED SEQUENCE 4-8, I.E., GLY-THR-PHE-THR-SER ARE ALSO CLASSIFIED IN DIGEST 640) (C07K-99/38) |
| | DIG651 | With all amino acids in L-form (C07K-99/38A) |
| | DIG652 | With at least one amino acid in D-form (C07K-99/40) |
| | DIG660 | PEPTIDES CONTAINING THE SQUENCE (CYS-SER-ASN-LEU-SER-THR-CYS -VAL LEU-SER-ALA-TYR-TRP-ARG -ASN-LEU-ASN-ASN-PHE-HIS -ARG-PHE-SER-GLY-MET GLY- PHE-GLY-PRO-GLU-THR-PRO-OH), E.G., A-THYROCALCITONIN, ETC., I.E., PORCINE OR RELATED PEPTIDES (C07K-99/42) |
| | DIG661 | With all amino acids in L-form (C07K-99/42A) |
| | DIG662 | With at least one amino acid in D-form (C07K-99/44) |
| | DIG670 | PEPTIDES CONTAINING THE SEQUENCE (CYS-GLY-ASN-LEU-SER-THR-CYS -MET LEU-GLY-THR-TYR- THR-GLU-ASP-PHE-ASN-LYS -PHE-HIS-THR-PHE-PRO -GLN THR-ALA-ILE-GLY- VAL-GLY-ALA-PRO-OH), E.G., CALCITONIN M (HUMAN) OR RELATED PEPTIDES (FRAGMENTS WHICH ARE COMMON WITH DIGEST 660 ARE ALSO IN THAT CLASSIFICATION) (C07K-99/46) |
| | DIG671 | With all amino acids in L-form (C07K-99/46A) |
| | DIG672 | With at least one amino acid in D-form (C07K-99/48) |
| | DIG680 | PEPTIDES CONTAINING THE SEQUENCE (HCO-VAL- ILE- GLY-ALA-LEU-ALA-VAL VAL- VAL-TRP-LEU-TRP- PHE- LEU-TRP-LEU-TRP-NHCH2CH2OH), E.G., GRAMICIDINS A OR B OR RELATED PEPTIDES (C07K-99/50) |
| | DIG681 | With all amino acids in L-form (C07K-99/50A) |
| | DIG682 | With at least one amino acid in D-form (C07K-99/52) |
| | DIG690 | PEPTIDES CONTAINING THE SEQUENCE (PGL-HIS-TRP-SER-TYR-GLY-LEU -ARG PRO-GLY-NH2), E.G., LH-RH, LRF, OR RELATED PEPTIDES (C07K-99/54) |
| | DIG691 | With all amino acids in L-form (C07K-99/54A) |
| | DIG692 | 1-Pgl, 10-Gly derivatives (C07K-99/54A1) |
| | DIG693 | Des-1-Pgl derivatives (C07K-99/54A2) |
| | DIG694 | Des-10-Gly derivatives (C07K-99/54A3) |
| | DIG695 | With at least one amino acid in D-form (C07K-99/56) |
| | DIG700 | PEPTIDES CONTAINING THE SEQUENCE (ALA-GLY-CYS-LYS-ASN-PHE-PHE- TRP LYS-THR-PHE-THR -SER-CYS-OH), E.G., SOMATOSTATIN, SRIF, OR RELATED PEPTIDES (C07K-99/58) |
| | DIG701 | All amino acids in L-form (C07K-99/58A) |
| | DIG702 | S-S bridge 3,14 being modified (for the reduced form Cys-3 or Cys-14 being modified) (C07K-99/58A1A) |
| | DIG706 | At least one amino acid in D-form (C07K-99/60) |
| | DIG720 | PEPTIDES CONTAINING THE SEQUENCE (TYR-GLY-GLY-PHE-MET-THR-SER- GLU LYS-SER-GLN-THR-PRO- LEU-VAL-THR-LEU-PHE-LYS-ASN- ALA-ILE-ILE-LYS-ASN ALA-HIS- LYS-LYS-GLY-GLU-OH), E.G., B-ENDORPHIN OR RELATED PEPTIDES (C07K-99/62) |
| | DIG721 | With all amino acids in L-form (C07K-99/62A) |
| | DIG722 | With at least one amino acid in D-form (C07K-99/64) |
| | DIG730 | PEPTIDES CONTAINING THE SEQUENCE (TYR-GLY-GLY-PHE-MET-THR-SER- GLU LYS-SER-GLN- THR-PRO-LEU-VAL-THR-OH), E.G., LIPOTROPIN OR RELATED PEPTIDES (FRAGMENTS WHICH ARE COMMON WITH DIGEST 720 ARE ALSO IN THAT CLASSIFICATION) (C07K-99/66) |
| | DIG731 | With all amino acids in L-form (C07K-99/66A) |
| | DIG732 | With at least one amino acid in D-form (C07K-99/68) |
| | DIG740 | PEPTIDES CONTAINING THE SEQUENCE (TRY-GLY-GLY-PHE-X), X BEING AN AMINO ACID, E.G., ENKEPHALINS OR RELATED PEPTIDES (SEQUENCES CONTAINING MORE THAN FIVE AMINO ACIDS ARE CLASSIFIED IN DIGESTS 720 OR 730) (C07K 99/70) |
| | DIG741 | With all amino acids in L-form (C07K-99/70A) |
| | DIG742 | With at least one amino acid in D-form (C07K-99/72) |
| | DIG750 | PEPTIDES CONTAINING THE SEQUENCE (ARG-LYS-ASP-VAL-TYR-VAL-), E.G., THYMIN I OR II, THYMOPOIETINS, OR RELATED PEPTIDES (C07K-99/74) |
| | DIG751 | With all amino acids in L-form (C07K-99/74A) |
| | DIG752 | With at least one amino acid in D-form (C07K-99/76) |
| | DIG760 | PEPTIDES CONTAINING THE SEQUENCE (ASP-A-GLY-PRO-TYR-B-MET- GLU-HIS PHE-ARG-TRP-GLY- SER-PRO-PRO-LYS-ASP-OH), A BEING GLU OR SER, B BEING LYS OR ARG, E.G., B-MELANOTROPINS OR RELATED PEPTIDES (C07K-99/78) |
| | DIG761 | With all amino acids in L-form (C07K-99/78A) |
| | DIG762 | With at least one amino acid in D-form (C07K-99/80) |
| | DIG770 | PEPTIDES CONTAINING THE SEQUENCE (THR-VAL-PRO-SER- (N-METHYL)VAL-) (C07K-99/82) |
| | DIG771 | With all amino acids in L-form (C07K-99/82A) |
| | DIG772 | With at least one amino acid in D-form (C07K-99/84) |
| | DIG780 | TETRAPEPTIDES (DERIVED FROM ONLY FOUR AMINO ACIDS) (C07K-5/10) |
| | DIG781 | Contains at least one ring formed only through peptide links (C07K 5/12B) |
| | DIG782 | With at least one amino acid in D-form (C07K-5/10Z) |
| | DIG783 | The first amino acid being heterocyclic (Pro) (C07K-5/10H) |
| | DIG784 | The first amino acid contains the same number of amino and carboxylic acid or derivative groups (neutral) (C07K-5/10A) |
| | DIG787 | The first amino acid contains more amino groups than carboxylic acid or derivative groups (basic) (C07K-5/10B) |
| | DIG788 | The first amino acid contains more carboxylic acid or derivative groups than amino groups (acidic) (C07K-5/10C) |
| | DIG790 | LINEAR PEPTIDES CONTAINING AT LEAST ONE ABNORMAL PEPTIDE LINK AND DERIVED FROM 5-100 AMINO ACIDS (C07K-7/02) |
| | DIG800 | LINEAR PEPTIDES CONTAINING ONLY NORMAL PEPTIDE LINKS AND DERIVED FROM 5 100 AMINO ACIDS (C07K-7/04) |
| | DIG801 | Contains only 5-11 amino acids (C07K-7/06) |
| | DIG802 | With all amino acids in L-form (C07K-7/06A) |
| | DIG803 | With at least one amino acid in D-form (C07K-06B) |
| | DIG810 | Contains only 12-20 amino acids (C07K-7/08) |
| | DIG811 | With all amino acids in L-form (C07K-7/08A) |
| | DIG812 | With at least one amino acid in D-form (C07K-7/08B) |
| | DIG820 | Contains 21-100 amino acids (C07K-7/10) |
This page is produced by the Office of Classification Support (Office of Patent Classification) for the Reference Tools Project.
Please send questions and comments to usptoinfo@uspto.gov .
Note: The Patent and Trademark Depository Library Program (PTDLP) administers a nationwide network of public, state and academic libraries designated as Patent and Trademark Depository Libraries authorized by 35 U.S.C. 13 to: Disseminate Patent and Trademark Information Support Diverse Intellectual Property Needs of the Public. PTDL Contact Information
Note: For information/comments on electronic information products, such as purchasing USPTO data, or to discuss system requirements for magnetic tape products, contact:
Information Products Division -- U.S. Patent and Trademark Office
Information Products Division
Contact Information
Or, browse
their on-line catalog.
The Inventors Assistance Center is available to help you on patent matters.Send questions about USPTO programs and services to the USPTO Contact Center (UCC). You can suggest USPTO webpages or material you would like featured on this section by E-mail to the webmaster@uspto.gov. While we cannot promise to accommodate all requests, your suggestions will be considered and may lead to other improvements on the website. |
|
|
=online
business system 
=fees 
=forms
=help 
=laws/regulations 
=definition
(glossary)